These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9734519)

  • 1. Bat lyssavirus prophylaxis in an immunocompromised patient.
    Crome MA; McCall BJ; Selvey LA; Howard SM
    Med J Aust; 1998 Aug; 169(3):175. PubMed ID: 9734519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Discussion on the article Ondrejková A et al.: Transmission of lyssavirus infections from bats to man. Klin mikrobiol inf lek 2003;9:280-3].
    Benes J; Korínková M
    Klin Mikrobiol Infekc Lek; 2004 Feb; 10(1):34. PubMed ID: 15100983
    [No Abstract]   [Full Text] [Related]  

  • 3. [Postexposure prophylaxis after bite of a broad-winged bat with evidence of European bat lyssavirus 1 (EBLV-1)].
    Fasse J; Trawinski H; Hardt M; Lübbert C
    Inn Med (Heidelb); 2024 Jun; 65(6):608-611. PubMed ID: 38100072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe.
    Echevarría JE; Banyard AC; McElhinney LM; Fooks AR
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses.
    Weir DL; Coggins SA; Vu BK; Coertse J; Yan L; Smith IL; Laing ED; Markotter W; Broder CC; Schaefer BC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus.
    Banyard AC; Selden D; Wu G; Thorne L; Jennings D; Marston D; Finke S; Freuling CM; Müller T; Echevarría JE; Fooks AR
    J Gen Virol; 2018 Dec; 99(12):1590-1599. PubMed ID: 29745870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veterinary surgeon's guide to Australian bat lyssavirus.
    Thompson GK
    Aust Vet J; 1999 Nov; 77(11):710-2. PubMed ID: 10685161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of rabies vaccine strains to elicit cross-neutralising antibodies.
    Brookes SM; Healy DM; Fooks AR
    Dev Biol (Basel); 2006; 125():185-93. PubMed ID: 16878476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
    Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1.
    Van Gucht S; Verlinde R; Colyn J; Vanderpas J; Vanhoof R; Roels S; Francart A; Brochier B; Suin V
    Acta Clin Belg; 2013; 68(1):54-8. PubMed ID: 23627196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.
    Servat A; Wasniewski M; Cliquet F
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31614675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on: 'Rabies and African bat lyssavirus encephalitis and its prevention'.
    Briggs DJ; Wilde H; Hemachuda T; Shantavasinkul P; Quiambao B; Sudarshan MK; Madhusudana SN
    Int J Antimicrob Agents; 2011 Feb; 37(2):182-3; author reply 183-4. PubMed ID: 21176874
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic and Antigenetic Characterization of the Novel Kotalahti Bat Lyssavirus (KBLV).
    Calvelage S; Tammiranta N; Nokireki T; Gadd T; Eggerbauer E; Zaeck LM; Potratz M; Wylezich C; Höper D; Müller T; Finke S; Freuling CM
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The other rabies viruses: The emergence and importance of lyssaviruses from bats and other vertebrates.
    Calisher CH; Ellison JA
    Travel Med Infect Dis; 2012 Mar; 10(2):69-79. PubMed ID: 22386761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabies and bat lyssavirus infection.
    N S W Public Health Bull; 2002; 13(1-2):27. PubMed ID: 12105675
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding human - bat interactions in NSW, Australia: improving risk communication for prevention of Australian bat lyssavirus.
    Quinn EK; Massey PD; Cox-Witton K; Paterson BJ; Eastwood K; Durrheim DN
    BMC Vet Res; 2014 Jul; 10():144. PubMed ID: 24984790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational lyssavirus risks and post-vaccination monitoring.
    Brookes SM; Fooks AR
    Dev Biol (Basel); 2006; 125():165-73. PubMed ID: 16878474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in postexposure prophylaxis of a vaccinated bat carer.
    Carroll HJ; McCall BJ; Looke D; Fraser B
    Med J Aust; 2011 Sep; 195(6):323-4. PubMed ID: 21929488
    [No Abstract]   [Full Text] [Related]  

  • 19. Australian bat lyssavirus infection in three fruit bats from north Queensland.
    Speare R; Skerratt L; Foster R; Berger L; Hooper P; Lunt R; Blair D; Hansman D; Goulet M; Cooper S
    Commun Dis Intell; 1997 May; 21(9):117-20. PubMed ID: 9145563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabies risk from contact with bats.
    Kirkbride H; Brown K; Morgan D; Larkin L
    Vet Rec; 2008 Oct; 163(16):491. PubMed ID: 18931360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.